Literature DB >> 20067234

Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Aaron Joseph L Villaraza1, Ambika Bumb, Martin W Brechbiel.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20067234      PMCID： PMC2868950          DOI： 10.1021/cr900232t

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  378 in total

Review 1.  Safety of magnetic resonance imaging contrast agents.

Authors:  F G Shellock; E Kanal
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

2.  Equilibrium phase MR angiography of the aortic arch and abdominal vasculature with the blood pool contrast agent CMD-A2-Gd-DOTA in pigs.

Authors:  L J Kroft; J Doornbos; S Benderbous; A de Roos
Journal:  J Magn Reson Imaging       Date:  1999-06       Impact factor: 4.813

3.  Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates.

Authors:  L H Bryant; M W Brechbiel; C Wu; J W Bulte; V Herynek; J A Frank
Journal:  J Magn Reson Imaging       Date:  1999-02       Impact factor: 4.813

4.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.

Authors:  L Josephson; C H Tung; A Moore; R Weissleder
Journal:  Bioconjug Chem       Date:  1999 Mar-Apr       Impact factor: 4.774

5.  Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience.

Authors:  A Gossmann; Y Okuhata; D M Shames; T H Helbich; T P Roberts; M F Wendland; S Huber; R C Brasch
Journal:  Radiology       Date:  1999-10       Impact factor: 11.105

6.  A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.

Authors:  D I Rosenthal; P Nurenberg; C R Becerra; E P Frenkel; D P Carbone; B L Lum; R Miller; J Engel; S Young; D Miles; M F Renschler
Journal:  Clin Cancer Res       Date:  1999-04       Impact factor: 12.531

7.  NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agent.

Authors:  K Adzamli; M P Periasamy; M Spiller; S H Koenig
Journal:  Invest Radiol       Date:  1999-06       Impact factor: 6.016

8.  Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.

Authors:  D L Ladd; R Hollister; X Peng; D Wei; G Wu; D Delecki; R A Snow; J L Toner; K Kellar; J Eck; V C Desai; G Raymond; L B Kinter; T S Desser; D L Rubin
Journal:  Bioconjug Chem       Date:  1999 May-Jun       Impact factor: 4.774

9.  CBF and CBV measurements by USPIO bolus tracking: reproducibility and comparison with Gd-based values.

Authors:  C Z Simonsen; L Ostergaard; P Vestergaard-Poulsen; L Røhl; A Bjørnerud; C Gyldensted
Journal:  J Magn Reson Imaging       Date:  1999-02       Impact factor: 4.813

10.  MRI of acute myocardial ischemia: comparing a new contrast agent, Gd-DTPA-24-cascade-polymer, with Gd-DTPA.

Authors:  H C Roberts; M Saeed; T P Roberts; A Mühler; R C Brasch
Journal:  J Magn Reson Imaging       Date:  1999-02       Impact factor: 4.813
View more
  91 in total

1.  High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation.

Authors:  Matthew W Rotz; Kayla S B Culver; Giacomo Parigi; Keith W MacRenaris; Claudio Luchinat; Teri W Odom; Thomas J Meade
Journal:  ACS Nano       Date:  2015-03-24       Impact factor: 15.881

2.  Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent.

Authors:  Young-Seung Kim; Yang Zhou; Henry Bryant; Diane E Milenic; Kwamena E Baidoo; Bobbi K Lewis; Joseph A Frank; Martin W Brechbiel
Journal:  Bioorg Med Chem Lett       Date:  2015-04-04       Impact factor: 2.823

3.  In Vivo MR Imaging of Fibrin in a Neuroblastoma Tumor Model by Means of a Targeting Gd-Containing Peptide.

Authors:  L Chaabane; L Tei; L Miragoli; L Lattuada; M von Wronski; F Uggeri; V Lorusso; S Aime
Journal:  Mol Imaging Biol       Date:  2015-12       Impact factor: 3.488

Review 4.  Click chemistry with polymers, dendrimers, and hydrogels for drug delivery.

Authors:  Enrique Lallana; Francisco Fernandez-Trillo; Ana Sousa-Herves; Ricardo Riguera; Eduardo Fernandez-Megia
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

5.  Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.

Authors:  Juan L Vivero-Escoto; Kathryn M L Taylor-Pashow; Rachel C Huxford; Joseph Della Rocca; Christie Okoruwa; Hongyu An; Weili Lin; Wenbin Lin
Journal:  Small       Date:  2011-11-09       Impact factor: 13.281

6.  Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform.

Authors:  Wojciech G Lesniak; Nikita Oskolkov; Xiaolei Song; Bachchu Lal; Xing Yang; Martin Pomper; John Laterra; Sridhar Nimmagadda; Michael T McMahon
Journal:  Nano Lett       Date:  2016-03-01       Impact factor: 11.189

Review 7.  Single-chain polymer nanoparticles.

Authors:  Miren Karmele Aiertza; Ibon Odriozola; Germán Cabañero; Hans-Jürgen Grande; Iraida Loinaz
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

Review 8.  Environmentally responsive MRI contrast agents.

Authors:  Gemma-Louise Davies; Iris Kramberger; Jason J Davis
Journal:  Chem Commun (Camb)       Date:  2013-10-28       Impact factor: 6.222

Review 9.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

10.  Biodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imaging.

Authors:  Juan L Vivero-Escoto; William J Rieter; Honam Lau; Rachel C Huxford-Phillips; Wenbin Lin
Journal:  Small       Date:  2013-04-24       Impact factor: 13.281
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.